Novel skin care compositions

a composition and skin technology, applied in the field of cosmetic compositions, can solve the problems of few systematic studies to support such claims, adverse effects on skin metabolism, and many side effects at the level of efficacy, and achieve the effect of reducing the toxicity of products, preserving bacteria efficiently, and low toxicity

Inactive Publication Date: 2007-03-01
BIOPHYSICA
View PDF15 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Wrinkles are skin folds and creases caused by dermal thinning and loss of elasticity, which is a result of the aging process and / or exposure to noxious substances and / or physical factors such as UV radiation, all of which adversely affect the skin metabolism.
There are many claims to inventions for non-surgical wrinkle reduction or removal, but there are few systematic studies to support such claims.
There is a plethora of facial creams available containing a variety of substances, many of which are either inefficient or induce side effects at the levels of efficacy.
Thus, it is known that topical vitamin C, tretinoin, or isotretinoin, while transiently improving the wrinkles caused by aging and photo damage, have a considerable incidence of irritation.
Inducing paresis of the muscle fibers for cosmetic purposes by substances blocking the neuromuscular junctions is not physiologically acceptable and has its own particular toxicity.
However, giving mammalian estrogens systemically for the sole purpose of reducing the signs of skin aging would not be medically defensible.
Therefore, topical mammalian estrogens for skin regeneration, although effective, cannot qualify as a cosmetic preparation and are not authorized in cosmetic creams.
However, in a topical application they are not resorbed systemically (Bayerl and Keil, 2002 Akt Dermatol 28:14-8).
IH is considered a skin hyperandrogenetic syndrome in the cosmetic category since especially dark excessive facial hair is visible and leads to psychological distress.
Cyproterone acetate (CPA), a progestagen with anti-androgenic properties, carries the risk of hypertension, thromboembolism, diabetes mellitus, hypercholesterolemia and endometrial cancer.
Mechanical depilation by tweezing and depilatory can potentially exacerbate IH by stimulating the growth of thicker and coarser hair, making subsequent treatments more difficult and occasionally inducing folliculitis and trauma to the hair shaft and skin.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel skin care compositions

Examples

Experimental program
Comparison scheme
Effect test

example 1

A Typical Composition 100 g of the Novel Skin Care Cosmetic Preparation

[0066] 0.5 g extract from Japanese knotweed (min. 95% trans-resveratrol); 3,4′,5-trihydroxy-trans-stilbene, CAS No.: [501-36-0]

[0067] 0.5 g extract from frankincense (Olibanum)—Boswellia serrata (60-70% triterpenes) CAS No.: [8050-07-5]

[0068] 0.5 g extract from vegetable oil Brassica oleifera / Glycine soja (unsaponifiable fractions CAS [91770-67-1]

[0069] 3.0 g vitamin E (DL-α-tocopherol acetate); 3,4-dihydro-2, 5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol acetate, 3.000 IU CAS No.: [7695-91-2]

[0070] 1.2 g vitamin A (retinol palmitate); 3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl) 2,4,6,8-nonatetraen-1-ol palmitate, 2,000.000 IU, CAS No.: [79-81-2]

[0071] 2.0 g fluridil CAS No.: [260980-89-0]

[0072] 0.1 g BHT (butylhydroxytoluene), 2,6-Di-tert-butyl-4-methylphenol CAS No.: [128-37-0]

[0073] 5.0 g rubbing alcohol (isopropanol), CAS No.: [67-63-0]

[0074] 40.0 g refined oil from grape seed, ...

example 2

Ocular Toxicity: Effects on the Ocular Fibroblasts

[0076] Rabbit corneal fibroblasts, to which Neutral Red is added in vitro, are exposed to the product at 15, 25 and 50% concentrations for I minute. The cell viability is measured by Optical Density. The culture medium serves as negative control. IC50 less than 50% was found, indicating that the product has a very low toxicity towards ocular mucous membranes, and is equivalent to the marketed products of the same category.

example 3

Evaluation of the Antimicrobial Properties

[0077] The test, according to USP XXV, is based on inoculating the product with 5 strains, i.e., S. aureus, P. aeruginosa, E. coli, C. albicans and A. niger, incubation at 20° C. with the counts performed at 7, 14, 21 and 28 days. The antimicrobial (“preserving”) efficiency of the product is considered positive when at day 14 the bacterial counts (measured by concentration CFU / g) are reduced by at least 2 logs and in the following 14 days continue to drop or stay equal to the starting counts. For yeasts / moulds the counts must be equal or lower at day 14 and 28, compared to the initial count.

TABLE 3CONCENTRATIONS MEASURED (CFU / g)SOUCHES / STRAINSINOCULUMJ7 / D7J14 / D14J21 / D21J28 / D28S. aureus1.90E+070.00E+000.00E+000.00E+000.00E+00P. aeruginosa2.30E+070.00E+000.00E+000.00E+000.00E+00E. coli1.10E+070.00E+000.00E+000.00E+000.00E+00C. albicans2.20E+070.00E+000.00E+000.00E+000.00E+00A. niger3.10E+070.00E+000.00E+000.00E+000.00E+00

[0078] The product...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Skin care compositions are provided comprising a highly hydrophobic substance, an alkaryl polyfluorocarbon, particularly a substituted phenyl-polyfluoroacylamino propanamide, an alkanol and refined oils and the oil triglyceride fractions in sufficient amount to provide substantial homogeneity. When employed for hirsutism, optionally antioxidants and moisturizer are added. For use against wrinkles, additionally vitamins, antioxidants and a mixture of extracts of naturally occurring substances are present.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS [0001] This application claims priority from U.S. Provisional Patent Application No. 60 / 713,882 filed on Sep. 1, 2005, which is hereby incorporated by reference in its entirety.STATEMENT OF GOVERNMENTAL SUPPORT [0002] This invention was not made with Government Support.REFERENCE TO SEQUENCE LISTING, COMPUTER PROGRAM, OR COMPACT DISK [0003] None. BACKGROUND OF THE INVENTION [0004] 1. Field of the Invention [0005] The field of this invention concerns cosmetic compositions, particularly skin care related to skin hormonal imbalance. [0006] 2. Related Art BACKGROUND [0007] Mammalian skin and associated characteristics, such as wrinkles and hair growth and loss, are significantly affected by hormones, and the individual skin responsiveness to their levels and ratios, since there is substantial interest in the treatment of skin and its associated characteristics, there have been numerous reports of treatment as palliatives and cures. 1. Wrinkle Redu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K8/97A61K36/31A61K36/48A61K36/87A61K36/324
CPCA61K8/678A61K8/70A61Q19/08A61Q7/02A61K36/889A61K36/87A61K36/48A61K36/31A61K8/97A61K2300/00A61K8/9794A61K8/9789A61P17/00
Inventor SOVAK, MILOSSELIGSON, ALLEN L.PROKOP, JIRI
Owner BIOPHYSICA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products